stockrow
Tuesday 3 November 2026
Export CI’s income statement to Excel — free account
Cigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024.
- Revenue
- +6.68%
- EPS
- +10.2%
- Free cash flow
- +66.9%
- Total debt
- +3.61%
Quarter to June 2026, against a year earlier
295.90
2.33
−0.78%
Follow CI
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
12.41 | 22.56 | 17.83 | 15.04 | 14.59 | 9.01 | 15.23 | 17.75 | 23.20 | 18.85 |
Piotroski F-Score |
8 | 7 | 5 | 9 | 6 | 8 | 7 | 6 | 7 | 7 |
Altman Z-Score |
2.62 | 2.43 | 2.21 | 2.33 | 1.93 | 1.83 | 1.66 | 0.70 | 1.50 | 1.21 |
P/S ratio |
0.27 | 0.31 | 0.47 | 0.55 | 0.45 | 0.47 | 0.50 | 0.96 | 1.22 | 0.87 |
P/FCF ratio |
8.75 | 8.64 | 8.90 | 13.52 | 12.86 | 8.21 | 9.11 | 14.45 | 14.06 | 9.72 |
Altman Z″-Score (non-manufacturers) |
1.10 | 0.88 | 1.02 | 1.15 | 0.98 | 1.10 | 0.66 | 0.37 | (0.52) | (0.80) |
Beneish M-Score |
(2.47) | (2.47) | (2.69) | (2.48) | (2.40) | (2.45) | (1.50) | (1.70) | (2.64) | (2.73) |
P/Operating CF |
11.94 | 14.85 | 62.12 | 47.41 | 18.15 | 17.69 | 27.52 | 371.78 | 88.38 | 40.92 |
Dividend Safety Score |
82 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.75 | 1.88 | 1.97 | 2.23 | 1.65 | 1.51 | 1.70 | 1.14 | 3.71 | 2.52 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.06 | 4.47 |
EV/Sales |
0.35 | 0.41 | 0.59 | 0.69 | 0.61 | 0.62 | 0.71 | 1.76 | 1.27 | 0.92 |
EV/EBITDA |
8.12 | 8.35 | 9.87 | 10.95 | 9.78 | 9.01 | 9.35 | 17.60 | 11.82 | 9.87 |
EV/Operating CF |
10.12 | 9.83 | 9.67 | 14.40 | 14.77 | 9.54 | 11.56 | 22.67 | 13.04 | 9.07 |
EV/FCF |
11.59 | 11.37 | 11.16 | 16.94 | 17.59 | 10.67 | 13.00 | 26.36 | 14.74 | 10.24 |
Quick Ratio |
0.72 | 0.65 | 0.65 | 0.69 | 0.68 | 0.77 | 0.61 | 0.62 | 0.38 | 0.39 |
Current Ratio |
0.72 | 0.65 | 0.65 | 0.69 | 0.68 | 0.77 | 0.61 | 0.62 | 0.38 | 0.39 |
Net Debt/EBITDA |
1.99 | 2.00 | 2.00 | 2.21 | 2.63 | 2.08 | 2.80 | 7.96 | 0.55 | 0.50 |
Debt/Assets |
19.92% | 20.51% | 20.25% | 21.61% | 21.74% | 21.18% | 24.01% | 27.72% | 8.81% | 8.48% |
Debt/Equity |
0.75 | 0.78 | 0.67 | 0.70 | 0.71 | 0.65 | 0.83 | 1.04 | 0.40 | 0.37 |
Asset Turnover |
1.75 | 1.60 | 1.32 | 1.21 | 1.12 | 1.03 | 0.99 | 0.45 | 0.69 | 0.68 |
Operating CF/Net income |
1.61 | 3.02 | 2.29 | 1.29 | 1.34 | 1.22 | 1.86 | 1.43 | 1.83 | 2.16 |
Capex/Depreciation |
(0.44) | (0.51) | (0.52) | (0.44) | (0.39) | (0.39) | (0.29) | (0.76) | (0.83) | (0.76) |
Interest Coverage |
6.53 | 6.56 | 5.90 | 6.88 | 6.57 | 5.67 | 4.80 | 8.35 | 15.64 | 11.11 |
| 14.33% | 7.85% | 11.36% | 14.60% | 11.02% | 17.68% | 11.82% | 9.63% | 16.31% | 14.49% | |
| 3.80% | 2.23% | 3.48% | 4.49% | 3.46% | 5.44% | 3.30% | 2.45% | 3.69% | 3.21% | |
ROIC |
8.76% | 8.96% | 7.69% | 7.56% | 6.55% | 6.97% | 6.46% | 3.26% | 15.23% | 12.39% |
Return on Tangible Assets |
(49.05%) | (21.79%) | (41.19%) | (75.39%) | (64.43%) | (199.29%) | (60.23%) | (35.17%) | (12.37%) | (10.04%) |
Average Days of Receivables |
43.64 | 42.25 | 42.16 | 45.77 | 42.02 | 39.57 | 37.59 | 119.89 | 77.86 | 87.54 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
5.32% | 6.01% | 7.59% | 7.30% | 7.48% | 8.77% | 9.15% | 24.53% | 23.99% | 24.57% |
Intangible Assets out of Total Assets |
0.47 | 0.47 | 0.49 | 0.54 | 0.52 | 0.51 | 0.52 | 0.55 | 0.11 | 0.10 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(1.03) | (1.01) | (0.84) | (0.71) | (1.06) | (1.02) | (1.17) | (1.97) | (0.71) | (0.95) |
Graham Number |
279.90 | 201.30 | 248.13 | 263.53 | 222.23 | 267.77 | 190.92 | 200.13 | 103.61 | 93.32 |
Earnings Yield |
8.06% | 4.43% | 5.61% | 6.65% | 6.85% | 11.10% | 6.57% | 5.63% | 4.31% | 5.31% |
Free Cash Flow Yield |
11.43% | 11.57% | 11.24% | 7.40% | 7.78% | 12.18% | 10.97% | 6.92% | 7.11% | 10.29% |
Revenue per Share |
1,030.58 | 881.65 | 664.41 | 583.17 | 515.05 | 439.48 | 408.51 | 197.24 | 166.63 | 156.01 |
Operating CF per Share |
35.99 | 36.97 | 40.20 | 27.96 | 21.28 | 28.36 | 25.23 | 15.28 | 16.29 | 15.77 |
Capex per Share |
(4.54) | (5.02) | (5.35) | (4.18) | (3.41) | (3.00) | (2.79) | (2.14) | (1.88) | (1.81) |
Free Cash Flow per Share |
31.45 | 31.96 | 34.84 | 23.78 | 17.86 | 25.36 | 22.44 | 13.14 | 14.41 | 13.96 |
Cash per Share |
28.78 | 26.94 | 26.62 | 19.14 | 15.03 | 27.90 | 12.29 | 15.63 | 11.85 | 12.47 |
Shareholders Equity per Share |
156.98 | 147.14 | 157.35 | 144.37 | 139.45 | 137.89 | 120.62 | 166.37 | 54.65 | 53.76 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
156.98 | 147.14 | 157.35 | 144.37 | 139.45 | 137.89 | 120.62 | 166.37 | 54.65 | 53.76 |
Free Cash Flow |
8,389.00 | 8,957.00 | 10,240.00 | 7,361.00 | 6,037.00 | 9,256.00 | 8,435.00 | 3,242.00 | 3,615.00 | 3,565.00 |
Working Capital |
(15,795.00) | (19,414.00) | (16,233.00) | (12,667.00) | (12,027.00) | (8,449.00) | (12,891.00) | (12,060.00) | (19,649.00) | (20,139.00) |
Capital Expenditures |
(1,212.00) | (1,406.00) | (1,573.00) | (1,295.00) | (1,154.00) | (1,094.00) | (1,050.00) | (528.00) | (471.00) | (461.00) |
Net Current Asset Value |
(75,498.00) | (78,483.00) | (76,138.00) | (70,639.00) | (82,637.00) | (77,550.00) | (89,995.00) | (92,356.00) | (36,158.00) | (32,893.00) |
EV/EBIT |
10.57 | 10.81 | 13.38 | 14.76 | 13.37 | 12.11 | 13.58 | 20.55 | 13.52 | 11.82 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
7.98 | 8.22 | 10.68 | 11.78 | 9.77 | 9.32 | 9.52 | 11.26 | 12.89 | 11.22 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.76 | 0.76 | 0.82 | 0.78 | 0.79 | 0.67 | 0.83 | 0.15 | 0.36 | 0.40 |
Cash ROIC |
10.36% | 11.09% | 12.05% | 9.01% | 7.03% | 9.91% | 9.65% | 3.71% | 16.34% | 16.25% |
Accounts Receivable Turnover |
8.94 | 9.66 | 8.64 | 8.46 | 9.30 | 9.66 | 9.66 | 3.91 | 4.53 | 3.97 |
Accounts Payable Turnover |
0.87 | 1.17 | 1.36 | 1.38 | 1.65 | 1.90 | 2.01 | 1.53 | 1.12 | 1.02 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
435.59 | 356.60 | 285.35 | 281.77 | 238.85 | 210.06 | 184.09 | 199.79 | 303.68 | 362.06 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
30,738.00 | 25,581.00 | 22,595.50 | 21,337.50 | 18,716.00 | 16,603.50 | 15,898.00 | 12,449.00 | 9,236.50 | 10,031.00 |
Average Payables |
39,375.50 | 33,063.50 | 26,606.50 | 23,404.50 | 20,394.50 | 17,184.50 | 15,306.00 | 18,043.50 | 22,582.00 | 23,837.50 |
Average Assets |
156,900.00 | 154,321.00 | 148,323.00 | 149,387.00 | 155,170.00 | 155,612.50 | 154,500.00 | 107,492.50 | 60,559.50 | 58,224.00 |
Average Common Equity |
41,558.50 | 43,743.50 | 45,466.00 | 45,909.00 | 48,729.00 | 47,836.00 | 43,189.50 | 27,373.00 | 13,719.00 | 12,885.50 |
Columns are period end dates